Monte Rosa Therapeutics (GLUE) Receivables - Other (2022 - 2026)
Monte Rosa Therapeutics (GLUE) recorded Receivables - Other of $4.92 million in Q2 2026, up 107.6% from $2.37 million a year earlier and up 6.7% from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Receivables - Other (2022 - 2026) Analysis & Trends
At the end of FY2025, Monte Rosa Therapeutics reported Receivables - Other of $4.6 million.
- Annual Receivables - Other has a three-year compound annual growth rate of -15.6% (FY2022 to FY2025).
- Across earlier years, Receivables - Other came in at $173,000 in FY2024 (-65.7%), $505,000 in FY2023 (-93.4%) and $7.66 million in FY2022.
- Quarterly Receivables - Other has ranged from $173,000 in Q4 2024 to $7.66 million in Q4 2022 over the past five years.
- On a year-over-year basis, Receivables - Other rose in six of the last seven quarters, with growth averaging 203.1%.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 734.5% in Q3 2025, against a decline of 93.4% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.61 million (Q1 2026), $4.6 million (Q4 2025) and $4.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Monte Rosa Therapeutics | 1.00 Bn | 412.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.92 Mn |
| Mar 31, 2026 | 4.61 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 595,000.00 |
| Jun 30, 2024 | 842,000.00 |
| Mar 31, 2024 | 601,000.00 |
| Dec 31, 2023 | 505,000.00 |
| Sep 30, 2023 | 294,000.00 |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | 7.66 Mn |
| Sep 30, 2022 | 4.05 Mn |
API Access
Monte Rosa Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();